HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate.

AbstractBACKGROUND:
Up to seven in every 1000 patients experience angioedema from angiotensin-converting enzyme (ACE) inhibitors, even after many years of use. In 2003, every 20th Norwegian used an ACE inhibitor.
CASE REPORT:
A 61-year-old woman with chronic obstructive pulmonary disease and a past acute myocardial infarction had used 7.5 mg of ramipril daily for the past 7 years. She also used acetylsalicylic acid, simvastatin, theophylline and salmeterol. One night she woke up with edema of the tongue. On hospital arrival, 250 mg of hydrocortisone and 5 mg of dexchlorpheniramine were given intravenously (i.v.) and 0.3 mg of epinephrine was given subcutaneously (s.c.). The edema of the tongue progressed over the next 8 h and made the tongue protrude. Fiberscopy revealed glassy edema of the arytenoids. Inspiratory stridor was heard and the patient could not speak. She became increasingly uneasy and restless. Berinert complement 1 (C1) inhibitor concentrate (1500 units) was administered i.v. Over the following 20 min, stridor gradually subsided, the patient calmed and she was able to talk.
DISCUSSION:
ACE inhibitor-provoked angioedema shares many clinical features with hereditary angioedema (HAE), including a limited effect of steroids, antihistamines and epinephrine. HAE, caused by excess bradykinin formation as a result of C1 inhibitor deficiency, usually has its laryngeal edema effectively reversed by C1 inhibitor in less than 0.5 h. Although patients experiencing ACE inhibitor-provoked angioedema have normal C1 inhibitor values, as in our patient, excess bradykinin is probably important as ACE breaks down bradykinin. It is unknown why ACE inhibitor-provoked angioedema appears in some and sometimes after many years of use.
CONCLUSION:
We believe that C1 inhibitor was effective in reversing the ACE inhibitor-induced angioedema in our patient.
AuthorsE W Nielsen, S Gramstad
JournalActa anaesthesiologica Scandinavica (Acta Anaesthesiol Scand) Vol. 50 Issue 1 Pg. 120-2 (Jan 2006) ISSN: 0001-5172 [Print] England
PMID16451161 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Complement C1 Inactivator Proteins
Topics
  • Airway Obstruction (etiology)
  • Angioedema (chemically induced, drug therapy)
  • Angiotensin-Converting Enzyme Inhibitors (adverse effects)
  • Complement C1 Inactivator Proteins (therapeutic use)
  • Female
  • Humans
  • Middle Aged
  • Tongue Diseases (chemically induced, diagnosis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: